Results 71 to 80 of about 8,075 (213)

Phylogenetic Relatedness Determines Heterospecific Pollen–Pistil Compatibility and Reproductive Outcome in the Apocarpous Species Sagittaria trifolia (Alismataceae)

open access: yesEcology and Evolution, Volume 16, Issue 1, January 2026.
This study investigates heterospecific pollen (HP) effects in Sagittaria trifolia, an apocarpous plant with an extragynoecial compitum. HP–pistil compatibility and resulting seed set reduction were greatest from phylogenetically close donors, not influenced by origin or pollen traits.
Si‐Yan Zou   +5 more
wiley   +1 more source

The complete mitochondrial genome sequence of Schisandra chinensis (Austrobaileyales: Schisandraceae)

open access: yesMitochondrial DNA. Part B. Resources, 2019
Chinese magnolia vine (Schisandra chinensis) is an economically important oriental medicinal plant that belongs to the Schisandraceae family. The complete mitochondrial genome sequence of S. chinensis was 946,141 bp in length.
Jeong-Ho Baek   +4 more
doaj   +1 more source

Lignans from Schisandra propinqua var. propinqua

open access: yesChemical and Pharmaceutical Bulletin, 2007
Two new dibenzocyclooctadiene lignans angeloyl-(+)-gomisin K(3) (1) and methylisogomisin O (2), together with six known ones, isogomisin O, angeloylisogomisin O, gomisin O, angeloygomisin O, benzoylgomisin O, epigomisin O, and four 1,4-bis(phenyl)-2,3-dimethylbutane type lignans, pregomisin, meso-dihydroguaiaretic acid, isoanwulignan, and sphenanlignan
Chun, Lei   +9 more
openaire   +3 more sources

Mechanisms of Action Involved in the In Vivo Gastroprotective Response of Fruits: A Systematic Review

open access: yesFood Frontiers, Volume 7, Issue 1, January 2026.
ABSTRACT Gastrointestinal diseases remain a significant global health concern, primarily due to the limitations of current pharmacological treatments, which often come with adverse side effects and high recurrence rates. This situation highlights the urgent need for safer and more effective alternatives.
Isabel Sousa Alcântara   +7 more
wiley   +1 more source

Content of adaptogens in vegetable Schizandra chinensis [PDF]

open access: yes, 2013
Tato diplomová práce se zabývá obsahem adaptanogenů v rostlině Schizandra chinensis. Teoretická část se zabývá rostlinou Schizandra chinensis, jejím výskytem, vlastnostmi, využitím a pěstováním.
Kozáková, Soňa
core  

The Lignan-containing Extract of Berries Inhibits the Growth of

open access: yesNatural Product Communications, 2015
The purpose of this study was to investigate the effect and selectivity of an extract of Schisandra chinensis berries against Chlamydia pneumoniae and C. trachomatis .
Elina Hakala   +4 more
doaj   +1 more source

Mechanism of Shenqi Qiangjing Granules in Treating Cyclophosphamide‐Induced Oligozoospermia Based on Network Pharmacology and Experimental Validation

open access: yesAndrologia, Volume 2026, Issue 1, 2026.
Background Research indicates that cyclophosphamide (CY), a cancer treatment, can cause oligozoospermia in men. Traditional Chinese medicine, particularly Shenqi Qiangjing (SQ) granules, may help improve this issue, but the exact way it works against CY–induced oligozoospermia is not completely clear.
Bing-Yu Xia   +7 more
wiley   +1 more source

Ципрофлоксацина гидрохлорида по реакции комплексообразования с железом (III) [PDF]

open access: yes, 2015
ЦИПРОФЛОКСАЦИНцифровое цветометрическое ...
Голубовская, А. А.   +1 more
core  

Pharmacokinetics of Schizandrin and Its Pharmaceutical Products Assessed Using a Validated LC–MS/MS Method

open access: yesMolecules, 2018
Schisandra chinensis has been used as an important component in various prescriptions in traditional Chinese medicine and, more recently, in Western-based medicine for its anti-hepatotoxic effect.
Chi-Lin Li   +3 more
doaj   +1 more source

Integrating Traditional Wisdom With Modern Science: Ginsenosides as Antiheart Failure Agents

open access: yesCardiovascular Therapeutics, Volume 2026, Issue 1, 2026.
Heart failure (HF), as the terminal stage of various cardiovascular diseases, remains a global health challenge with persistently high morbidity and mortality rates. Although current therapies—including angiotensin receptor–neprilysin inhibitors, sodium‐glucose cotransporter‐2 inhibitors, and cardiac resynchronization therapy—have improved outcomes ...
Li Zhou   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy